Your browser doesn't support javascript.
loading
Filamin C variants are associated with a distinctive clinical and immunohistochemical arrhythmogenic cardiomyopathy phenotype.
Hall, Charlotte L; Akhtar, Mohammed M; Sabater-Molina, Maria; Futema, Marta; Asimaki, Angeliki; Protonotarios, Alexandros; Dalageorgou, Chrysoula; Pittman, Alan M; Suarez, Mari Paz; Aguilera, Beatriz; Molina, Pilar; Zorio, Esther; Hernández, Juan Pedro; Pastor, Francisco; Gimeno, Juan R; Syrris, Petros; McKenna, William J.
Afiliación
  • Hall CL; Centre for Heart Muscle Disease, Institute of Cardiovascular Science, University College London, London, UK.
  • Akhtar MM; Centre for Heart Muscle Disease, Institute of Cardiovascular Science, University College London, London, UK.
  • Sabater-Molina M; Laboratorio de Cardiogenética, Instituto Murciano de Investigación Biosanitaria and Universidad de Murcia, Murcia, Spain.
  • Futema M; Centre for Heart Muscle Disease, Institute of Cardiovascular Science, University College London, London, UK.
  • Asimaki A; Cardiology Clinical Academic Group, Molecular and Clinical Sciences Research Institute, St Georges University of London, London, UK.
  • Protonotarios A; Centre for Heart Muscle Disease, Institute of Cardiovascular Science, University College London, London, UK.
  • Dalageorgou C; Centre for Heart Muscle Disease, Institute of Cardiovascular Science, University College London, London, UK.
  • Pittman AM; Molecular and Clinical Sciences Research Institute, St Georges University of London, London, UK.
  • Suarez MP; Instituto Nacional de Toxicologia y Ciencias Forenses de Madrid (INTCF), Madrid, Spain.
  • Aguilera B; Instituto Nacional de Toxicologia y Ciencias Forenses de Madrid (INTCF), Madrid, Spain.
  • Molina P; Department of Pathology at the Instituto de Medicina Legal y Ciencias Forenses de Valencia (IMLCF-Valencia), Histology Unit at the Universitat de València, Research Group on Inherited Heart Diseases, Sudden Death and Mechanisms of Disease (CaFaMuSMe) from the Instituto de Investigación Sanitaria (II
  • Zorio E; Cardiology Department at Hospital Universitario y Politécnico La Fe and Research Group on Inherited Heart Diseases, Sudden Death and Mechanisms of Disease (CaFaMuSMe) from the Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, Spain.
  • Hernández JP; Instituto de Medicina Legal de Murcia (IML-Murcia), Murcia, Spain.
  • Pastor F; Servicio de Cardiologia del Hospital Universitario Virgen de la Arrixaca and Departamento de Medicina Interna de la Universidad de Murcia, Murcia, Spain.
  • Gimeno JR; Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
  • Syrris P; Centre for Heart Muscle Disease, Institute of Cardiovascular Science, University College London, London, UK. Electronic address: p.syrris@ucl.ac.uk.
  • McKenna WJ; Centre for Heart Muscle Disease, Institute of Cardiovascular Science, University College London, London, UK.
Int J Cardiol ; 307: 101-108, 2020 05 15.
Article en En | MEDLINE | ID: mdl-31627847
ABSTRACT

BACKGROUND:

Pathogenic variants in the filamin C (FLNC) gene are associated with inherited cardiomyopathies including dilated cardiomyopathy with an arrhythmogenic phenotype. We evaluated FLNC variants in arrhythmogenic cardiomyopathy (ACM) and investigated the disease mechanism at a molecular level.

METHODS:

120 gene-elusive ACM patients who fulfilled diagnostic criteria for arrhythmogenic right ventricular cardiomyopathy (ARVC) were screened by whole exome sequencing. Fixed cardiac tissue from FLNC variant carriers who had died suddenly was investigated by histology and immunohistochemistry.

RESULTS:

Novel or rare FLNC variants, four null and five variants of unknown significance, were identified in nine ACM probands (7.5%). In FLNC null variant carriers (including family members, n = 16) Task Force diagnostic electrocardiogram repolarization/depolarization abnormalities were uncommon (19%), echocardiography was normal in 69%, while 56% had >500 ventricular ectopics/24 h or ventricular tachycardia on Holter and 67% had late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (CMRI). Ten gene positive individuals (63%) had abnormalities on ECG or CMRI that are not included in the current diagnostic criteria for ARVC. Immunohistochemistry showed altered key protein distribution, distinctive from that observed in ARVC, predominantly in the left ventricle.

CONCLUSIONS:

ACM associated with FLNC variants presents with a distinctive phenotype characterized by Holter arrhythmia and LGE on CMRI with unremarkable ECG and echocardiographic findings. Clinical presentation in asymptomatic mutation carriers at risk of sudden death may include abnormalities which are currently non-diagnostic for ARVC. At the molecular level, the pathogenic mechanism related to FLNC appears different to classic forms of ARVC caused by desmosomal mutations.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Displasia Ventricular Derecha Arritmogénica / Filaminas / Cardiomiopatías Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Cardiol Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Displasia Ventricular Derecha Arritmogénica / Filaminas / Cardiomiopatías Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Cardiol Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido